Additionally, our previous studies found that tumor PD-L1 and PD-L2 expression was associated with favorable outcomes in COAD patients due to compensatory stimulation of IFNγ+CD8+ T cells within the tumor microenvironment 28, 29. The gene discussed is PDCD1LG2; the disease is neoplasm.